Huang et al. (2022) found that a transformer-based image classifier (Xu et al., 2021) could differentiate MS from NMOSD and myelin oligodendrocyte glycoprotein antibody disease as accurately as two neuroradiologists. This evidence concerns the gene OMG and myeloid sarcoma.